2 exciting small cap ASX shares to watch

Doctor Care Anywhere Ltd (ASX:DOC) and this ASX small cap share could be worth watching closely in 2021…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I'm a big fan of small cap shares so feel quite fortunate to have such a large number of them on the Australian share market.

Two small cap ASX shares that could have bright futures are listed below. Here's what you need to know about them:

Doctor Care Anywhere Ltd (ASX: DOC)

The first small cap ASX share to watch is Doctor Care Anywhere. It is a growing UK-based telehealth company aiming to deliver high-quality, effective, and efficient care to its patients, whilst reducing the overall cost of providing clinical services.

Its shares landed on the Australian share market late last year after completing an IPO which raised $102 million. Management advised that the majority of the funds raised will be used to execute the company's growth strategy. This strategy is focused on its investment in marketing and engagement capabilities, new services to drive growth in existing markets, and building international business development capabilities to pursue growth in new markets.

Given the growing popularity of telehealth, it will come as no surprise to learn that the company is growing quickly. Last month it released a fourth quarter update and revealed a 151% increase in revenue to 3.8 million pounds. This led to the company's unaudited full year revenue increasing 102% year on year to 11.6 million pounds.

Pointerra Ltd (ASX: 3DP)

Another small cap ASX share to watch is Pointerra. It is a growing technology company with a focus on the commercialisation of 3D geospatial data. The company's software solution allows users to manage, visualise, and share extremely large digital 3D datasets. It can also extract vital information from the data quickly that would otherwise take many hours to do.

Pointerra has been growing very strongly over the last 12 months. Positively, this strong growth continued during the second quarter and into the third. As of 29 January, the company's Annual Contract Value (ACV) stood at US$6.88 million. This is an increase of US$1.06 million or 18% since its last update on 25 November. It is also up 262% since this time last year.

Management advised that this was driven partly by new customers in the US energy utilities and the US and Australian mapping sectors.

The good news is that its current ACV is still only a tiny portion of its overall market opportunity. Management estimates that its global market opportunity is currently worth a massive $500 billion annually.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Pointerra Limited. The Motley Fool Australia has recommended Doctor Care Anywhere Group PLC and Pointerra Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Speculative

surprised asx investor appearing incredulous at hearing asx share price
Speculative

'Blockbuster opportunity': This speculative ASX stock could rise 70%

Bell Potter thinks exciting times could be around the corner for this buy-rated high risk stock.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Healthcare Shares

Buy this small cap ASX stock with a 'lucrative opportunity'

Bell Potter thinks this speculative stock could have major upside thanks to its US market opportunity.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Speculative

Broker says this speculative ASX stock could rise over 200%

This high risk option could have major upside according to analysts.

Read more »

Vanadium Resources share price person riding rocket indicating share price increase
Speculative

Meet the speculative ASX stock tipped to rise 180%

Bell Potter thinks this share could almost triple in value.

Read more »

People sit in rollercoaster seats with expressions of fear, terror and exhilaration as it goes into a steep downward descent representing the Novonix share price in FY22
AI Stocks

Brainchip share price tumbles 40% in the past year. What's next?

Brainchip shares have had a topsy-turvy year. So, what’s next for this speculative ASX AI technology stock?

Read more »

A man balances on a tightrope across rocks above the sea at sunset.
Speculative

My top high-risk, high-reward ASX shares to buy in March

If you go into it with your eyes open about the pitfalls, speculative stocks could be fine in a well…

Read more »

A group of three scientists talking excitedly while working in a lab on a diabetes test developed by Proteomics International Laboratories which is an ASX share tipped to explode by Alto Capital
Ask a Fund Manager

2 'outstanding' small-cap ASX shares that could explode: expert

Ask A Fund Manager: Alto Capital's Tony Locantro reveals a pair of small caps that he reckons have a bright…

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Technology Shares

Why is the Weebit Nano share price rocketing 23% higher?

Weebit Nano shares are on fire on Wednesday...

Read more »